Randomized, Double-blind, Placebo-controlled Phase I-Ib Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain.
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2016
At a glance
- Drugs P 3914 (Primary)
- Indications Dental pain
- Focus Adverse reactions
- 11 Apr 2012 Status changed from recruiting to suspended as reported by Clinical Trials Registry - India record.
- 21 Mar 2012 Planned number of patients changed from 85 to 90 as reported by Clinical Trials Registry - India.
- 18 Jan 2012 Piramal Healthcare as company and lead trial centre added as reported by ClinicalTrials.gov.